Spogen Biotech Inc. — Form D
Spogen Biotech Inc. of COLUMBIA, MO, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-09. The offering totals $500K, of which $55K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-09-09
- Form: D
- Accession: 0001529296-11-000002
- Industry: Biotechnology
- Exemptions: 04.1, 04.2, 04.3
- Total offering: $500K
- Amount sold: $55K
- Remaining: $445K
- Minimum investment: $500
- Investors: 3
- Date of first sale: 2011-08-28
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-165575
Issuer
- Name: Spogen Biotech Inc.
- CIK: 0001529296
- Entity type: Corporation
- Jurisdiction: MISSOURI
- Incorporated: 2011
- Address: 1601 SOUTH PROVIDENCE RD., COLUMBIA, MO, 65211
- Phone: 573-884-7442
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Brian Matthew Thompson | Director | Columbia, MO |
| Brian Matthew Thompson | Executive Officer | Columbia, MO |
| Katie Lynn Capkovic Thompson | Executive Officer | Columbia, MO |
| Katie Lynn Capkovic Thompson | Director | Columbia, MO |
| Steven Lynn Capkovic Trampe | Director | Columbia, MO |
Other filings by this issuer (1)
More